Sign up
Pharma Capital

Genedrive extends global reach taking diagnostic Hepatitis-C test into Asia-Pacific

David Budd, chief executive of the diagnostics specialist genedrive PLC (LON:GDR), tells Proactive they've extended the “commercial reach” of their relationship with Sysmex Corp, signing a distribution deal with the Japanese group’s Asia-Pacific arm.

Under the agreement, Sysmex will be responsible for sales, marketing and customer support for the CE-marked Genedrive HCV ID Kit and platform in the region.


View full GDR profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.